Turcotte Robert E, Ferrone Marco, Isler Marc H, Wong Cynthia
McGill University Health Centre, Montréal, Que.
Can J Surg. 2009 Feb;52(1):51-5.
Soft-tissue sarcoma involving the popliteal fossa remains challenging because it is difficult to achieve wide margins with limb salvage in this location. Adjuvant therapy is frequently necessary, and limb function can be adversely affected. We reviewed our experience with these tumours.
Our prospective tumour database served to identify all patients with popliteal sarcomas treated at the McGill University Health Centre and the Maisonneuve-Rosemont Hospital between 1994 and 2005. We assessed oncologic and functional outcomes as well as complications.
Our study included 18 patients (12 women and 6 men). The mean age was 54 (range 16-84) years. The mean duration of follow-up was 55 (range 4-126) months. Frequent histologic diagnoses were liposarcoma (n = 6), synovial sarcoma (n = 4) and leiomyosarcoma (n = 3). Tumour size varied from 2 to 21 cm (median 11 cm). American Joint Committee on Cancer staging was as follows: 4 patients had stage IIa disease, 3 patients had stage IIb, 10 patients had stage III and 1 patient had stage IV disease. Treatment consisted of limb salvage in 15 patients and amputation in 3. Fourteen patients had radiotherapy, 4 had chemotherapy, and 3 needed partial sciatic nerve resection. Margins were negative in 7 of 18 patients and microscopically positive in 11 patients. Complications included wound infections in 3 patients and thrombophlebitis in 2 patients. Of the patients undergoing limb-salvaging procedures, 1 experienced local recurrences after limb salvage (7%), and 5 experienced lung metastases (20%). Local recurrence was always associated with positive margins, whereas metastases occurred only in patients without local recurrence. The mean Musculoskeletal Tumor Society 1987 score was 33 (range 24-35). The mean Toronto Extremity Salvage Score results was 82.4 (range 63.8-100). At latest follow-up, 6 patients had died of disease, 1 was alive with disease, and 11 (61%) patients remained free of disease.
Despite the high rate of microscopically positive margins, the local recurrence rate was 7%. Amputation did not prevent death. We found function to be good to excellent in most patients who had limb-salvaging surgery.
累及腘窝的软组织肉瘤治疗仍具有挑战性,因为在此部位进行保肢手术时难以获得足够的安全切缘。辅助治疗常常是必要的,且肢体功能可能受到不利影响。我们回顾了我们在这些肿瘤治疗方面的经验。
我们的前瞻性肿瘤数据库用于识别1994年至2005年间在麦吉尔大学健康中心和迈松纳夫-罗塞蒙特医院接受治疗的所有腘窝肉瘤患者。我们评估了肿瘤学和功能结局以及并发症。
我们的研究纳入了18例患者(12例女性和6例男性)。平均年龄为54岁(范围16 - 84岁)。平均随访时间为55个月(范围4 - 126个月)。常见的组织学诊断为脂肪肉瘤(n = 6)、滑膜肉瘤(n = 4)和平滑肌肉瘤(n = 3)。肿瘤大小从2厘米至21厘米不等(中位数为11厘米)。美国癌症联合委员会分期如下:4例患者为IIa期疾病,3例患者为IIb期,10例患者为III期,1例患者为IV期疾病。15例患者接受了保肢手术,3例患者接受了截肢手术。14例患者接受了放疗,4例患者接受了化疗,3例患者需要进行部分坐骨神经切除。18例患者中有7例切缘阴性,11例患者切缘镜下阳性。并发症包括3例患者发生伤口感染,2例患者发生血栓性静脉炎。在接受保肢手术的患者中,1例患者在保肢术后出现局部复发(7%),5例患者发生肺转移(20%)。局部复发总是与切缘阳性相关,而转移仅发生在无局部复发的患者中。肌肉骨骼肿瘤学会1987年评分的平均值为33分(范围24 - 35分)。多伦多肢体挽救评分结果的平均值为82.4分(范围63.8 - 100分)。在最近一次随访时,6例患者死于疾病,1例患者带瘤生存,11例(61%)患者无疾病生存。
尽管镜下切缘阳性率较高,但局部复发率为7%。截肢并不能预防死亡。我们发现大多数接受保肢手术的患者功能良好至优秀。